Lenalidomide and ILT2 blockade enhance NK cell function in chronic lymphocytic Leukemia

dc.contributor.author	Villa Álvarez, Mónica
dc.contributor.author	Sordo Bahamonde, Christian
dc.contributor.author	Lorenzo Herrero, Seila
dc.contributor.author	González Rodríguez, Ana Pilar
dc.contributor.author	Ramírez Payer, Ángel
dc.contributor.author	González García, María Esther
dc.contributor.author	Villa Álvarez, María Cristina
dc.contributor.author	López Soto, Alejandro
dc.contributor.author	González Rodríguez, Segundo
dc.date.accessioned	2020-04-29T10:56:50Z
dc.date.available	2020-04-29T10:56:50Z
dc.date.issued	2019
dc.identifier.issn	0014-2980
dc.identifier.issn	1521-4141
dc.identifier.uri	http://hdl.handle.net/10651/54665
dc.description	International Congress of Immunology (IUIS) (17th. 2019. Beijing, China)
dc.format.extent	p. 1766-1767
dc.language.iso	eng
dc.relation.ispartof	European Journal Of Immunology, 49(S3)
dc.rights	© 2019 The Authors \| European Journal of Immunology
dc.rights	© WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
dc.source	WOS:000490026905488
dc.title	Lenalidomide and ILT2 blockade enhance NK cell function in chronic lymphocytic Leukemia
dc.type	conference output	spa
dc.relation.publisherversion	https://doi.org/10.1002/eji.201970400

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.